Shopping Cart
Remove All
Your shopping cart is currently empty
MM 419447 is a guanylate cyclase-C agonist, and it is a metabolite of linaclotide. This compound, MM 419447, shows promise in the field of irritable bowel syndrome with constipation (IBS-C) research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $849 | Inquiry | Inquiry |
| Description | MM 419447 is a guanylate cyclase-C agonist, and it is a metabolite of linaclotide. This compound, MM 419447, shows promise in the field of irritable bowel syndrome with constipation (IBS-C) research. |
| In vitro | MM 419447 demonstrates strong binding affinity for T84 cells, leading to a notable, concentration-dependent increase in intracellular cyclic guanosine-3',5'-monophosphate (cGMP)[1]. |
| In vivo | Administration of MM 419447 at a dosage of 10 mg/kg orally to female Sprague-Dawley rats resulted in peak plasma concentration (Cmax) of 27 ng/mL, an area under the curve (AUC0-6) of up to 29.7 ng·h/mL, and a half-life (t1/2) of 0.33 hours, according to pharmacokinetic analysis[1]. |
| Molecular Weight | 1363.55 |
| Formula | C50H70N14O19S6 |
| Cas No. | 1092457-78-7 |
| Smiles | [H][C@@]12CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@]1([H])CSSC[C@H](N)C(=O)N[C@@]3([H])CSSC[C@]([H])(NC(=O)[C@H](C)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CSSC[C@]([H])(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N1)C(O)=O |
| Relative Density. | 1.60 g/cm3 (Predicted) |
| Sequence Short | CCEYCCNPACTGC (Disulfide bridge:Cys1-Cys6; Cys2-Cys10; Cys5-Cys13) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.